These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
60 related articles for article (PubMed ID: 1666551)
1. Development of beta-adrenoceptor number and subtype distribution in the transplanted human heart. Zerkowski HR; Khamssi M; Brodde OE Eur Heart J; 1991 Dec; 12 Suppl F():124-6. PubMed ID: 1666551 [TBL] [Abstract][Full Text] [Related]
2. Beta-adrenoceptors in the transplanted human heart: unaltered beta-adrenoceptor density, but increased proportion of beta 2-adrenoceptors with increasing posttransplant time. Brodde OE; Khamssi M; Zerkowski HR Naunyn Schmiedebergs Arch Pharmacol; 1991 Oct; 344(4):430-6. PubMed ID: 1685012 [TBL] [Abstract][Full Text] [Related]
3. Decrease in beta 1- and increase in beta 2-adrenoceptors in long-term follow-up after orthotopic cardiac transplantation. Steinfath M; von der Leyen H; Hecht A; Neumann KH; Schmitz W; Scholz H; Haverich A; Heublein B J Mol Cell Cardiol; 1992 Oct; 24(10):1189-98. PubMed ID: 1336061 [TBL] [Abstract][Full Text] [Related]
4. The effect of orthotopic transplantation on total, beta 1- and beta 2-adrenoceptors in the human heart. Chester MR; Madden B; Barnett D; Yacoub M Br J Clin Pharmacol; 1992 Apr; 33(4):417-22. PubMed ID: 1315563 [TBL] [Abstract][Full Text] [Related]
5. Regional distribution of beta-adrenoceptors in the human heart: coexistence of functional beta 1- and beta 2-adrenoceptors in both atria and ventricles in severe congestive cardiomyopathy. Brodde OE; Schüler S; Kretsch R; Brinkmann M; Borst HG; Hetzer R; Reidemeister JC; Warnecke H; Zerkowski HR J Cardiovasc Pharmacol; 1986; 8(6):1235-42. PubMed ID: 2434752 [TBL] [Abstract][Full Text] [Related]
7. Beta-adrenergic supersensitivity of the transplanted human heart is presynaptic in origin. Gilbert EM; Eiswirth CC; Mealey PC; Larrabee P; Herrick CM; Bristow MR Circulation; 1989 Feb; 79(2):344-9. PubMed ID: 2536597 [TBL] [Abstract][Full Text] [Related]
8. Specific non-beta-adrenergic binding sites for 125I-iodocyanopindolol in myocardial membrane preparations: a comparative study between human, rat, and porcine hearts. Bjørnerheim R; Golf S; Hansson V Cardiovasc Res; 1991 Sep; 25(9):764-73. PubMed ID: 1666020 [TBL] [Abstract][Full Text] [Related]
9. Lymphocyte beta 2-adrenoceptors mirror precisely beta 2-adrenoceptor, but poorly beta 1-adrenoceptor changes in the human heart. Michel MC; Beckeringh JJ; Ikezono K; Kretsch R; Brodde OE J Hypertens Suppl; 1986 Dec; 4(6):S215-8. PubMed ID: 2886571 [TBL] [Abstract][Full Text] [Related]
10. Interaction between simvastatin and metoprolol with respect to cardiac beta-adrenoceptor density, catecholamine levels and perioperative catecholamine requirements in cardiac surgery patients. Nette AF; Abraham G; Ungemach FR; Oertel R; Kirch W; Leineweber K; Mohr FW; Dhein S Naunyn Schmiedebergs Arch Pharmacol; 2005 Aug; 372(2):115-24. PubMed ID: 16215713 [TBL] [Abstract][Full Text] [Related]
11. Selective regulation of beta 1- and beta 2-adrenoceptors in the human heart by chronic beta-adrenoceptor antagonist treatment. Michel MC; Pingsmann A; Beckeringh JJ; Zerkowski HR; Doetsch N; Brodde OE Br J Pharmacol; 1988 Jul; 94(3):685-92. PubMed ID: 2902891 [TBL] [Abstract][Full Text] [Related]
12. Functional beta3-adrenoceptor in the human heart. Gauthier C; Tavernier G; Charpentier F; Langin D; Le Marec H J Clin Invest; 1996 Jul; 98(2):556-62. PubMed ID: 8755668 [TBL] [Abstract][Full Text] [Related]
13. Down-regulated beta-adrenoceptors in severely failing human ventricles: uniform regional distribution, but no increased internalization. Pitschner HF; Droege A; Mitze M; Schlepper M; Brodde OE Basic Res Cardiol; 1993; 88(2):179-91. PubMed ID: 8389122 [TBL] [Abstract][Full Text] [Related]
14. Beta-adrenoceptor density and relative number of beta-adrenoceptor subtypes in biopsies from human right atrial, left ventricular, and right ventricular myocard. Golf S; Løvstad R; Hansson V Cardiovasc Res; 1985 Oct; 19(10):636-41. PubMed ID: 2996771 [TBL] [Abstract][Full Text] [Related]
15. Reduced alpha 1- and beta 2-adrenoceptor-mediated positive inotropic effects in human end-stage heart failure. Steinfath M; Danielsen W; von der Leyen H; Mende U; Meyer W; Neumann J; Nose M; Reich T; Schmitz W; Scholz H Br J Pharmacol; 1992 Feb; 105(2):463-9. PubMed ID: 1348446 [TBL] [Abstract][Full Text] [Related]
16. Lack of effect of chronic calcium antagonist treatment on beta 1- and beta 2-adrenoceptors in right atria from patients with or without heart failure. Brodde OE; Hundhausen HJ; Zerkowski HR; Michel MC Br J Clin Pharmacol; 1992 Mar; 33(3):269-74. PubMed ID: 1315561 [TBL] [Abstract][Full Text] [Related]
17. Myocardial beta-adrenoceptors and inhibitory G-proteins in myocardial biopsies and in explanted hearts from patients with dilated cardiomyopathy. Böhm M; Gierschik P; Schnabel P; Erdmann E Cardioscience; 1990 Jun; 1(2):109-17. PubMed ID: 1966374 [TBL] [Abstract][Full Text] [Related]
18. Characterization and autoradiographic localization of beta-adrenoceptor subtypes in human cardiac tissues. Buxton BF; Jones CR; Molenaar P; Summers RJ Br J Pharmacol; 1987 Oct; 92(2):299-310. PubMed ID: 2823947 [TBL] [Abstract][Full Text] [Related]
19. Human heart beta-adrenoceptors: beta1-adrenoceptor diversification through 'affinity states' and polymorphism. Molenaar P; Chen L; Semmler AB; Parsonage WA; Kaumann AJ Clin Exp Pharmacol Physiol; 2007 Oct; 34(10):1020-8. PubMed ID: 17714089 [TBL] [Abstract][Full Text] [Related]
20. Regional distribution of beta 1- and beta 2-adrenoceptors in the failing and nonfailing human heart. Steinfath M; Lavicky J; Schmitz W; Scholz H; Döring V; Kalmár P Eur J Clin Pharmacol; 1992; 42(6):607-11. PubMed ID: 1320570 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]